Tonix Pharmaceuticals Holding (TNXP) Change in Account Payables (2010 - 2026)

Tonix Pharmaceuticals Holding has reported Change in Account Payables for 17 years, with the latest figure at -$596000.0 in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 119.45% year-over-year to -$596000.0 in Q2 2026; TTM through Jun 2026 was $1.2 million, a 139.8% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 222.98% from the prior year.
• Change in Account Payables was -$596000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, down from $1.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $3.7 million in Q2 2024, with the low at -$6.4 million in Q3 2024.
• Average Change in Account Payables over 5 years is $17944.4, with a median of $578000.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 1844.87% in 2022, then slumped 725.07% in 2024.
• Over 5 years, Change in Account Payables stood at $3.0 million in 2022, then plunged by 229.73% to -$3.9 million in 2023, then surged by 114.76% to $581000.0 in 2024, then sank by 227.02% to -$738000.0 in 2025, then gained by 19.24% to -$596000.0 in 2026.
• The last three Change in Account Payables figures came in at -$596000.0 (Q2 2026), $1.5 million (Q1 2026), and -$738000.0 (Q4 2025), per Business Quant data.